title: Metrifonate treatment enhances acquisition of eyeblink conditioning in aging rabbits.
abstract: The cholinergic system is known to show deterioration during aging and Alzheimer's disease. In response, a therapeutic approach to Alzheimer's disease has been to attempt to compensate for the decrease in central cholinergic function by potentiating the activity of the remaining intact cholinergic cells with cholinesterase inhibitors. In this study treatment with the long-lasting cholinesterase inhibitor metrifonate enhanced acquisition of eyeblink conditioning in aging rabbits without producing interfering side effects. The effects of metrifonate on central and peripheral cholinesterase activity were evaluated, as was the involvement of plasma atropine esterase activity on the central and peripheral response to metrifonate. Results demonstrate that metrifonate can produce predictable, dose-dependent ChE inhibition. Associative learning in the aging rabbit was improved by metrifonate-induced steady state ChE inhibition within a range of 30-80%. Metrifonate was behaviorally effective in the absence of the severe side effects which typically plague cholinesterase inhibitors, suggesting that metrifonate is a possible treatment for the cognitive deficits resulting from normal aging and Alzheimer's disease.
authors.affiliation: Department of Cell & Molecular Biology, Northwestern University Medical School, Chicago, IL 60611, USA.
authors.forename: M A
authors.initials: MA
authors.lastname: Kronforst-Collins
authors.forename: P L
authors.initials: PL
authors.lastname: Moriearty
authors.forename: M
authors.initials: M
authors.lastname: Ralph
authors.forename: R E
authors.initials: RE
authors.lastname: Becker
authors.forename: B
authors.initials: B
authors.lastname: Schmidt
authors.forename: L T
authors.initials: LT
authors.lastname: Thompson
authors.forename: J F
authors.initials: JF
authors.lastname: Disterhoft
mesh_terms: D000375:Aging / Q000523:psychology*; D000818:Animals; D001767:Blinking / Q000187:drug effects*; D001921:Brain / Q000201:enzymology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D002802:Cholinesterases / Q000097:blood / Q000378:metabolism; D003214:Conditioning, Classical / Q000187:drug effects*; D004305:Dose-Response Relationship, Drug; D004912:Erythrocytes / Q000201:enzymology; D005260:Female; D010812:Physical Stimulation; D011817:Rabbits; D013268:Stimulation, Chemical; D014236:Trichlorfon / Q000494:pharmacology*
chemical_list: D002800:Cholinesterase Inhibitors; D014236:Trichlorfon; D002802:Cholinesterases